Shiro Shirakura

401 total citations
25 papers, 339 citations indexed

About

Shiro Shirakura is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shiro Shirakura has authored 25 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shiro Shirakura's work include Inflammatory mediators and NSAID effects (7 papers), Cholesterol and Lipid Metabolism (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Shiro Shirakura is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Cholesterol and Lipid Metabolism (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Shiro Shirakura collaborates with scholars based in Japan and Singapore. Shiro Shirakura's co-authors include Akira Karasawa, Kozo Yao, Shinichi Uchida, Makoto Takayama, Norihiro Suzuki, Tomoyuki Kanda, Yoshinori Nagata, Koji Yamada, Kazuhiro Kubo and Junichi Sano and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Shiro Shirakura

24 papers receiving 327 citations

Peers

Shiro Shirakura

CCM

PHYSI

EDM

M.A. Villalobos Spain

Pan-Yue Deng China

Toshiaki Akira Japan

Kanoo Hosoki Japan

Chiu‐Yin Kwan Canada

Jacek Petrusewicz Poland

Mauro Miceli Italy

Chan-Juan Huo China

О. И. Алиев Russia

Asami Hashino Japan

M.A. Villalobos Spain

Shiro Shirakura

56 ×0.6

60 ×0.7

CCM

63 ×0.9

PHYSI

29 ×0.4

EDM

62 ×1.0

Citations per year, relative to Shiro Shirakura Shiro Shirakura (= 1×) peers M.A. Villalobos

Countries citing papers authored by Shiro Shirakura

Since Specialization

Citations

This map shows the geographic impact of Shiro Shirakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Shirakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Shirakura more than expected).

Fields of papers citing papers by Shiro Shirakura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Shirakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Shirakura. The network helps show where Shiro Shirakura may publish in the future.

Co-authorship network of co-authors of Shiro Shirakura

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Shirakura. A scholar is included among the top collaborators of Shiro Shirakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Shirakura. Shiro Shirakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sugimoto, Yoshiyuki, Kiyotoshi Mori, Hiroshi Ishida, et al.. (2013). K-685, a TRPV1 Antagonist, Blocks PKC-Sensitized TRPV1 Activation and Improves the Inflammatory Pain in a Rat Complete Freund’s Adjuvant Model. Journal of Pharmacological Sciences. 123(3). 256–266. 9 indexed citations

Ishida, Hiroshi, et al.. (2012). Discovery of Novel 5,5-Diarylpentadienamides as Orally Available Transient Receptor Potential Vanilloid 1 (TRPV1) Antagonists. Journal of Medicinal Chemistry. 55(7). 3436–3451. 50 indexed citations

Yamada, Koji, Shinichi Uchida, Makoto Takayama, et al.. (2010). Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease. Brain Research. 1352. 176–186. 78 indexed citations

Kitayama, Tetsuya, Kozo Yao, Shiro Shirakura, et al.. (2008). Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. European Journal of Pharmacology. 584(2-3). 424–434. 49 indexed citations

Yao, Kozo, Hiroshi Maeda, Yasuhiro Ina, et al.. (2006). Combined Effects of Benidipine and Diltiazem on Cardiohemodynamics in Anesthetized Dogs. Biological and Pharmaceutical Bulletin. 29(4). 730–734. 1 indexed citations

Sano, Junichi, et al.. (2004). Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats. Pathology International. 54(12). 904–913. 18 indexed citations

Yao, Kozo & Shiro Shirakura. (2004). Combined Effects of Benidipine and Diltiazem in a Rat Model of Experimental Angina. Journal of Pharmacological Sciences. 95(3). 394–397. 9 indexed citations

Yao, Kozo, et al.. (2003). Renoprotective Effects of Benidipine in Combination with Angiotensin II Type 1 Receptor Blocker in Hypertensive Dahl Rats. Hypertension Research. 26(8). 635–641. 22 indexed citations

Shirakura, Shiro, et al.. (1996). Inhibitors of Acyl-CoA: Cholesterol Acyltransferase. II. Preparation and Hypocholesterolemic Activity of Optically Active Dibenz(b,e)oxepin-11-carboxanilides.. Chemical and Pharmaceutical Bulletin. 44(1). 222–225. 4 indexed citations

10.

Shirakura, Shiro, et al.. (1995). N-(1-phenyl-2-benzimidazolyl)-N′-phenylurea derivatives as potent in hibitors of acylcoa:cholesterol acyltransferase (ACAT). Bioorganic & Medicinal Chemistry Letters. 5(16). 1829–1832. 3 indexed citations

11.

Shirakura, Shiro, Katsuya Higo, Masami Takeda, & Akira Karasawa. (1994). Antithrombotic Effects of KW-3635, a Thromboxane A2-Receptor Antagonist, in Guinea Pigs.. The Japanese Journal of Pharmacology. 65(2). 93–98. 13 indexed citations

12.

OBASE, H., et al.. (1994). Inhibitors of Acyl-CoA:Cholesterol Acyltransferase. 1. Synthesis and Hypocholesterolemic Activity of Dibenz[b,e]oxepin-11-carboxanilides. Journal of Medicinal Chemistry. 37(6). 804–810. 11 indexed citations

13.

Shirakura, Shiro, Katsuya Higo, Masami Takeda, & Akira Karasawa. (1994). Antithrombotic Effects of KW-3635, a Thromboxane A2-Receptor Antagonist, in Guinea Pigs. The Japanese Journal of Pharmacology. 65(2). 93–98. 5 indexed citations

14.

Shirakura, Shiro, Akira Karasawa, & Kazumi Kubo. (1993). Effect of Benidipine Hydrochloride (KW-3049), on Cerebral Ischemia Induced by Bilateral Occlusion of the Common Carotid Arteries in Rats.. Biological and Pharmaceutical Bulletin. 16(5). 475–479. 7 indexed citations

15.

Ohshima, Etsuo, Hideyuki Sato, H. OBASE, et al.. (1992). Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 2. Journal of Medicinal Chemistry. 35(18). 3402–3413. 4 indexed citations

16.

Shirakura, Shiro, Junichi Sano, Akira Karasawa, & Kazuhiro Kubo. (1992). Protective Effect of Benidipine against the Development of Glomerular Sclerosis in Experimental Nephrotic Syndrome. The Japanese Journal of Pharmacology. 59(4). 461–467. 10 indexed citations

17.

Shirakura, Shiro, Junichi Sano, Akira Karasawa, & Kazuhiro Kubo. (1992). Protective Effects of Benidipine on Arachidonic Acid-Induced Acute Cerebral Ischemia in Rats. The Japanese Journal of Pharmacology. 59(1). 15–22. 8 indexed citations

18.

Karasawa, Akira, Shiro Shirakura, Katsuya Higo, et al.. (1991). Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.. PubMed. 41(12). 1230–6. 9 indexed citations

19.

Karasawa, Akira, Shiro Shirakura, Katsuya Higo, & Kazuhiro Kubo. (1991). Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.. PubMed. 41(12). 1237–41. 8 indexed citations

20.

Shirakura, Shiro, Akira Karasawa, & Kazuhiro Kubo. (1991). Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats.. PubMed. 41(12). 1242–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact